Sensory neuropathy and metabolic risk factors in human immune deficiency virus infected South Africans receiving protease inhibitors.

Vermaak, John-Randel; Dave, Joel A; Levitt, Naomi; Heckmann, Jeannine M

Vermaak, John-Randel; Dave, Joel A; Levitt, Naomi; Heckmann, Jeannine M.

Afiliación

Vermaak JR; Neurology Research Group, Division of Neurology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Dave JA; Division of Endocrinology and Diabetic Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Levitt N; Division of Endocrinology and Diabetic Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Heckmann JM; Neurology Research Group, Division of Neurology, Department of Medicine, University of Cape Town, Cape Town, South Africa.

AIDS Res Ther ; 12: 30, 2015.

Article en En | MEDLINE | ID: mdl-26401157

Palabras clave

African; Anti-retroviral therapy; Distal sensory polyneuropathy; Dysglycemia; Lopinavir; Metabolic; Protease inhibitors; Ritonavir; Symptomatic neuropathy; Triglycerides

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: AIDS Res Ther Año: 2015 Tipo del documento: Article País de afiliación: Sudáfrica

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google